Lamotrigine and Bupropion for Meniere's Disease

Summary

This is a double-blind, placebo-controlled clinical trial to assess whether treatment with lamotrigine and bupropion is more effective than placebo to reduce definitive Meniere's vertigo attacks (DMVA) and dizziness in patients with Meniere's disease. Thirty four participants will be randomized to treatment or placebo groups. Each participant will take part in the trial for 34 weeks, or approximately 9 months.

Timeline

Start

2020-12-16

Primary completion

2024-07

Completion

2024-12

Drugs

Indications